Chie Morita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chie Morita has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Atsushi Kitamura
St. Luke's International Hospital, Tokyo, Japan
3 shared publications Shosei Ro
Department of Pulmonary Medicine, Thoracic Center St. Luke's International Hospital Tokyo Japan
3 shared publicationsJin Takasaki
Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan
2 shared publicationsKohei Okafuji
Department of Respiratory Medicine, Thoracic Center St. Luke's International Hospital Tokyo Japan
2 shared publicationsNaoki Nishimura
Department of Respiratory Medicine, Thoracic Center St. Luke's International Hospital Tokyo Japan
2 shared publicationsNorio Ohmagari
Department of Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
2 shared publications
Latest Publications
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA5080
Clinical characteristics of different subspecies in patients with Mycobacterium intracellulare pulmonary disease
Introduction: In recent years, various subspecies of Mycobacterium intracellulare have been identified. However, there are still limited reports on the clinical characteristics of each subspecies. In this study, we examined the clinical characteristics of three subspecies of M. intracellulare: M. intracellulare subsp. intracellulare, M. intracellulare subsp. paraintracellulare, and M. intracellulare subsp. chimaera. Methods: We performed genomic analysis on strains stored in our hospital from 2015 to 2021 and reviewed medical records of patients. The primary endpoints were unfavorable outcomes such as smear-positive conversions, worsening imaging findings, hospitalization, and death. Results: A total of 128 patients were screened, and 91 patients met the ATS/ERS/ESCMID/IDSA Clinical Practice Guideline diagnostic criteria. Patients with less than six months of follow-up were excluded, and 61 patients were included in the analysis. Of these, 22 had subsp. intracellulare, 29 had subsp. paraintracellulare, and 10 had subsp. chimaera. The median age of each group was 71.5/ 73/ 66.5 years, and the proportion of patients over 60 years old was similar among the three groups. Although there were fewer women in M. chimaera group, there were no significant differences in BMI, underlying diseases, or smoking history. Furthermore, there were also no significant differences in the cumulative incidence of unfavorable outcomes. Conclusion: Our study found no significant differences in the clinical background or clinical course among the three subspecies of M. intracellulare. However, larger studies are needed to further examine the clinical characteristics of each subspecies.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA5080
Clinical characteristics of different subspecies in patients with Mycobacterium intracellulare pulmonary disease
Introduction: In recent years, various subspecies of Mycobacterium intracellulare have been identified. However, there are still limited reports on the clinical characteristics of each subspecies. In this study, we examined the clinical characteristics of three subspecies of M. intracellulare: M. intracellulare subsp. intracellulare, M. intracellulare subsp. paraintracellulare, and M. intracellulare subsp. chimaera. Methods: We performed genomic analysis on strains stored in our hospital from 2015 to 2021 and reviewed medical records of patients. The primary endpoints were unfavorable outcomes such as smear-positive conversions, worsening imaging findings, hospitalization, and death. Results: A total of 128 patients were screened, and 91 patients met the ATS/ERS/ESCMID/IDSA Clinical Practice Guideline diagnostic criteria. Patients with less than six months of follow-up were excluded, and 61 patients were included in the analysis. Of these, 22 had subsp. intracellulare, 29 had subsp. paraintracellulare, and 10 had subsp. chimaera. The median age of each group was 71.5/ 73/ 66.5 years, and the proportion of patients over 60 years old was similar among the three groups. Although there were fewer women in M. chimaera group, there were no significant differences in BMI, underlying diseases, or smoking history. Furthermore, there were also no significant differences in the cumulative incidence of unfavorable outcomes. Conclusion: Our study found no significant differences in the clinical background or clinical course among the three subspecies of M. intracellulare. However, larger studies are needed to further examine the clinical characteristics of each subspecies.
- Open Access
- 21 March 2023
- Published by Wiley in Respirology Case Reports
- Vol. 11 (4) , e01126
Difficult removal after bronchial filling of an endobronchial Watanabe spigot with N‐butyl‐2‐cyanoacrylate for intractable pneumothorax: A case report
A 52‐year‐old man developed a right pneumothorax during treatment for COVID‐19. In a previous case report concerning this patient, his recovery was achieved through implanting four endobronchial Watanabe spigots (EWS) in the right B1 and B3 in two phases and spraying N‐butyl‐2‐cyanoacrylate (NBCA). One year later, EWS removal was planned. He was intubated under bronchoscopic guidance, and the right upper lobe was observed. The right B1 and B3 inlets were found to be covered with granuloma. Despite the presence of a nylon thread for easy retrieval and partial debridement of the granulation, removal of the implanted EWS in the right B1 and B3 using grasping forceps, basket forceps, and two types of balloons under fluoroscopic guidance was challenging. NBCA spraying is a possible cause of foreign body granuloma formation. Therefore, careful consideration of the indications for the combined EWS‐NBCA procedure is necessary.
- 21 March 2023
- Published by Wiley in Respirology Case Reports
- Vol. 11 (4) , e01126
Open AccessDifficult removal after bronchial filling of an endobronchial Watanabe spigot with N‐butyl‐2‐cyanoacrylate for intractable pneumothorax: A case report
A 52‐year‐old man developed a right pneumothorax during treatment for COVID‐19. In a previous case report concerning this patient, his recovery was achieved through implanting four endobronchial Watanabe spigots (EWS) in the right B1 and B3 in two phases and spraying N‐butyl‐2‐cyanoacrylate (NBCA). One year later, EWS removal was planned. He was intubated under bronchoscopic guidance, and the right upper lobe was observed. The right B1 and B3 inlets were found to be covered with granuloma. Despite the presence of a nylon thread for easy retrieval and partial debridement of the granulation, removal of the implanted EWS in the right B1 and B3 using grasping forceps, basket forceps, and two types of balloons under fluoroscopic guidance was challenging. NBCA spraying is a possible cause of foreign body granuloma formation. Therefore, careful consideration of the indications for the combined EWS‐NBCA procedure is necessary.
- Open Access
- 17 October 2022
- Published by Wiley in Respirology Case Reports
- Vol. 10 (11) , e01050
A case of a thoracic mass negative on thoracentesis diagnosed by cryobiopsy from the visceral pleura
Thoracoscopy under local anaesthesia is recommended for malignant tumours with negative pleural effusion cytology. Cryobiopsy from the visceral pleura by thoracoscopy under local anaesthesia can provide more diagnostic options for patients with thoracentesis‐negative malignant effusions. Here we present the first case in which this technique was used. The patient had a pleural metastasis that could not be diagnosed even with rapid cytology of the parietal pleura biopsy. Indications, technical pitfalls, and safety tips are discussed.
- 17 October 2022
- Published by Wiley in Respirology Case Reports
- Vol. 10 (11) , e01050
Open AccessA case of a thoracic mass negative on thoracentesis diagnosed by cryobiopsy from the visceral pleura
Thoracoscopy under local anaesthesia is recommended for malignant tumours with negative pleural effusion cytology. Cryobiopsy from the visceral pleura by thoracoscopy under local anaesthesia can provide more diagnostic options for patients with thoracentesis‐negative malignant effusions. Here we present the first case in which this technique was used. The patient had a pleural metastasis that could not be diagnosed even with rapid cytology of the parietal pleura biopsy. Indications, technical pitfalls, and safety tips are discussed.
- 29 March 2022
- Published by Taylor & Francis
- p. 425-430
Knowledge Discovery from Numerical Data
Since many real data consist of numerical data, the discovery of understandable propositions from numerical data is important, and can be regarded as inductive learning with continuous classes. However, inductive learning in AI can be applied only to classification problems with discrete classes, and cannot be applied to the problems with continuous classes. One of the authors previously presented an algorithm for discovering understandable propositions from numerical data. The algorithm consists of normalization, multiple regression analysis and the approximation of multilinear functions by continuous Boolean functions. However, since the approximation algorithm is exponential in computational complexity, it can hardly be applied to real databases. This paper presents a polynomial approximation algorithm and applies the algorithm to a stock database to discover understandable propositions representing static relations and dynamic relations among stock prices.
- 29 March 2022
- Published by Taylor & Francis
- p. 425-430
Knowledge Discovery from Numerical Data
Since many real data consist of numerical data, the discovery of understandable propositions from numerical data is important, and can be regarded as inductive learning with continuous classes. However, inductive learning in AI can be applied only to classification problems with discrete classes, and cannot be applied to the problems with continuous classes. One of the authors previously presented an algorithm for discovering understandable propositions from numerical data. The algorithm consists of normalization, multiple regression analysis and the approximation of multilinear functions by continuous Boolean functions. However, since the approximation algorithm is exponential in computational complexity, it can hardly be applied to real databases. This paper presents a polynomial approximation algorithm and applies the algorithm to a stock database to discover understandable propositions representing static relations and dynamic relations among stock prices.
- Open Access
- 13 March 2022
- Published by Wiley in Respirology Case Reports
- Vol. 10 (4) , e0923
Combined treatment with endobronchial Watanabe spigot andN‐butyl‐2‐cyanoacrylate for refractory pneumothorax inCOVID‐19
Coronavirus disease 2019 (COVID‐19) causes pneumothorax or mediastinal emphysema in approximately 1% of patients. According to the British Thoracic Society guidelines, the next treatment option for patients with persistent pneumothorax despite chest drainage is pleurodesis or surgery. In fact, there are reports of autologous blood pleurodesis or surgery for the treatment of pneumothorax caused byCOVID‐19. However, elderly patients or patients in poor general condition may not be able to tolerate surgical invasion. In this report, we present two patients who did not respond to chest drainage or pleurodesis and who were not suitable for surgery because of their poor general condition. These patients were successfully treated with an endobronchial Watanabe spigot andN‐butyl‐2‐cyanoacrylate. This method may be an option for the treatment of refractory pneumothorax inCOVID‐19.
- 13 March 2022
- Published by Wiley in Respirology Case Reports
- Vol. 10 (4) , e0923
Open AccessCombined treatment with endobronchial Watanabe spigot andN‐butyl‐2‐cyanoacrylate for refractory pneumothorax inCOVID‐19
Coronavirus disease 2019 (COVID‐19) causes pneumothorax or mediastinal emphysema in approximately 1% of patients. According to the British Thoracic Society guidelines, the next treatment option for patients with persistent pneumothorax despite chest drainage is pleurodesis or surgery. In fact, there are reports of autologous blood pleurodesis or surgery for the treatment of pneumothorax caused byCOVID‐19. However, elderly patients or patients in poor general condition may not be able to tolerate surgical invasion. In this report, we present two patients who did not respond to chest drainage or pleurodesis and who were not suitable for surgery because of their poor general condition. These patients were successfully treated with an endobronchial Watanabe spigot andN‐butyl‐2‐cyanoacrylate. This method may be an option for the treatment of refractory pneumothorax inCOVID‐19.
- 26 November 2021
- Published by Elsevier in Respiratory Investigation
- Vol. 60 (2) , 241-247
Clinical outcomes of corticosteroids for COVID-19 patients at the National Center for Global Health and Medicine during the first wave of infections
- 26 November 2021
- Published by Elsevier in Respiratory Investigation
- Vol. 60 (2) , 241-247
Clinical outcomes of corticosteroids for COVID-19 patients at the National Center for Global Health and Medicine during the first wave of infections